Acenocoumarol Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 1 mg, 2 mg, 4 mg
Reference Brands: Sintrom(EU)
Category:
Blood Disorder
Acenocoumarol inhibits vitamin K epoxide reductase, reducing the synthesis of clotting factors II, VII, IX, and X. It prevents blood clots, strokes, and deep vein thrombosis. Benefits include effective oral anticoagulation, rapid onset, and suitability for long-term therapy, helping reduce the risk of thromboembolic events.
Acenocoumarol tablet is available in Tablet
and strengths such as 1 mg, 2 mg, 4 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Acenocoumarol tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Acenocoumarol tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Acenocoumarol is a registered oral anticoagulant primarily used in the EU for managing thromboembolic disorders. In the EU, it is approved by the EMA under centralized or national authorization processes, with a comprehensive dossier demonstrating safety, efficacy, and quality. In the US, acenocoumarol is not widely marketed; Warfarin is the preferred anticoagulant. For successful registration, dossier preparation, and regulatory compliance, visit PharmaTradz. Ensuring adherence to regional regulations and pharmacovigilance standards is essential for market approval and safe use of acenocoumarol in different territories.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing